Stéphanie Forté: Bringing Cutting-Edge Genomic and Proteomic Tools to Sickle Cell Disease Patients
Stéphanie Forté, Principal Researcher at the Innovation Hub at the CHUM Research Center (CRCHUM), shared Guillaume Lettre’s post on LinkedIn:
“Precision medicine is making its entry into sickle cell disease (sickle cell disease).
Patients with this chronically underfunded and little-known disease deserve the same genomic and proteomic tools.
Thank you Guillaume Lettre, Pr Pablo Bartolucci, Cristian Groza for this great advance!”
Guillaume Lettre, Professor of Medicine at University of Montreal, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in PLoS Genetics, adding:
“Sickle cell disease affects more than 7 million people worldwide.
It is the most common monogenic disease in the world, yet it remains chronically neglected and underfunded, and patients still have very few therapeutic options.
We believe these patients deserve the same cutting-edge genomic tools that are now routinely applied to diseases more common in wealthier populations.
That is the spirit of our new paper, out now in PLoS Genetics.
We measured more than 5,000 plasma proteins in sickle cell disease patients and mapped the genetic variants that regulate their levels (pQTLs).
This is, to our knowledge, one of the first large-scale proteogenomic resources built specifically in this population.
We also used these results to prioritize circulating proteins that may influence fetal hemoglobin, the major protective factor in sickle cell disease and a key therapeutic target.
Congratulations to Cristian Groza, who led this work, and to all our collaborators, including Pablo Bartolucci and the team in Créteil.
Above all, thank you to the patients who made this research possible.
And Canadian Institutes of Health Research for the funding.
There is much more to do, and we hope this resource will help others bring modern genomics to sickle cell disease.”
Title: Proteogenomic analysis of 5,411 plasma proteins in sickle cell disease patients
Authors: Cristian Groza, Arnaud Chignon, Ken Sin Lo, Vanessa Bellegarde, Pablo Bartolucci, Guillaume Lettre

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 20, 2026, 11:19EHC Urges Equal Early Diagnosis for Bleeding Disorders
-
Nov 20, 2026, 11:14Pushpinder Singh: How Do We Know if Haemodialysis is Effective?
-
Nov 20, 2026, 11:09Neel Patel: Hematocon 2026 – Advancing Hematology Through Knowledge, Collaboration and Innovation
-
Nov 20, 2026, 11:03Alok Khorana: First FXI Inhibitor Approved in the US
-
Nov 20, 2026, 06:51How YERM Shapes the Careers of Future Hematology Researchers – EHA
-
Nov 20, 2026, 06:44Ann Van De Velde: Emerging Advances in Hemoglobinopathies, Sickle Cell Disease and Rare Anemias
-
Nov 20, 2026, 06:29Markus Müller: ABO Blood Groups and the Rare Bombay Phenotype
-
Nov 20, 2026, 05:57Lance Reed: Specialized Blood Components and Clinical Samples for Research and Diagnostics
-
Nov 20, 2026, 05:41Sundas Anjum: Community Engagement and Blood Donation for Thalassemia Care